← Leaderboards
Ella Fung Jones
Visen Medical, Inc.
$2,001,686
Attributed
$4,148,291
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $671.3K · FY2008–21$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,148,291 · 7
By mechanism
R01$3,705,164 · 2
R44$298,452 · 1
R43$99,216 · 1
P41$45,459 · 3
Top collaborators
- Nola M. Hylton3 shared
- Thea D Tlsty3 shared
- Ignasi Vivas3 shared
Most similar at Visen Medical, Inc.
Same institution · by research overlap
- Milind Rajopadhye$1,352,201
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsImageMalignant Breast NeoplasmPositron-Emission TomographyRadiotracerUptakeMolecularMonitorLesionMammographyCharacteristicsResponseSignal TransductionTumorCellsLeadDoseDesignResearch PersonnelBaseCostBiomarkerAreaBiological Heterogeneity
Grant awards (11)
Dedicated breast PET and MRI for characterization of breast cancer and its response to therapy$580,052
R01 · FY2021 · CA
Dedicated breast PET and MRI for characterization of breast cancer and its response to therapy$582,942
R01 · FY2020 · CA
Dedicated breast PET and MRI for characterization of breast cancer and its response to therapy$601,146
R01 · FY2019 · CA
MOLECULAR IMAGING OF METASTATIC LYMPH NODES IN BREAST CANCER$133
P41 · FY2011 · RR · contact PI
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy$634,250
R01 · FY2010 · CA
MOLECULAR IMAGING OF METASTATIC LYMPH NODES IN BREAST CANCER$37,095
P41 · FY2010 · RR · contact PI
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy$640,750
R01 · FY2009 · CA
MOLECULAR IMAGING OF METASTATIC LYMPH NODES IN BREAST CANCER$8,231
P41 · FY2009 · RR · contact PI
Characterizing the Evolution of Pre-malignant Tissues at High Risk for Malignancy$666,024
R01 · FY2008 · CA
Molecular Beacons for Clinical Cancer Imaging$298,452
R44 · FY2003 · CA
Molecular Beacons for Clinical Cancer Imaging$99,216
R43 · FY2002 · CA